4 Healthcare Stock Stories for Tuesday Wellness

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Sanofi-Aventis (NYSE:SNY): Current price $49.62

On Tuesday, Sanofi reported that its experimental diabetes drug lixisenatide has been accepted for review by the FDA. The United States brand name for the medication, known as Lyxumia in Europe, is under consideration.


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business